US biotech IGM Biosciences (Nasdaq: IGMS), which is developing and delivering medicines to treat patients with autoimmune and inflammatory diseases, announced a strategic update to halt further ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 4 undervalued ...

After losing its powerhouse partner, IGM Biosciences closed “most” of its labs and offices and initiated a strategic review ...

Sanofi has scrapped its collaboration with IGM Biosciences, eliminating the biotech’s last program in the process. IGM responded by laying off 80% of its staff and closing most of its lab and ...

On Monday, IGM Biosciences, Inc., a pharmaceutical company based in Mountain View, California, announced the termination of a significant collaboration and license agreement with Genzyme Corporation, ...

The partnership with Sanofi, which focuses on IgM-based agonists targeting autoimmune and inflammatory diseases, includes three preclinical candidates with potential milestone payments exceeding ...